Aethir's digital asset reserve, Predictive Oncology (NASDAQ: POAI), has officially launched on the Nasdaq under the ticker symbol $POAI. The company plans to acquire $45 million worth of ATH tokens from the open market over the next 45 days. This move follows Predictive Oncology's recent completion of $343.5 million in PIPE financing, aimed at bolstering its ATH token treasury strategy.
Aethir's Digital Asset Reserve POAI Debuts on Nasdaq, Plans $45M ATH Purchase
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.